Working Capital Loan ContractWorking Capital Loan Contract • January 30th, 2024 • Universe Pharmaceuticals INC • Pharmaceutical preparations
Contract Type FiledJanuary 30th, 2024 Company IndustrySpecial Notice: In order to protect the legitimate rights and interests of the Borrower, the Lender hereby requests the Borrower to give full attention to all provisions concerning the rights and obligations of the parties, especially those shown in bold. If the Borrower has any objection, it shall raise the objection to the Lender. Otherwise, after this Contract is entered into by and between the Borrower and the Lender, all the terms and conditions herein represent the true intention of both parties, are protected by law, and shall be legally binding on both parties herein.
Working Capital Loan ContractWorking Capital Loan Contract • January 30th, 2024 • Universe Pharmaceuticals INC • Pharmaceutical preparations • Macau
Contract Type FiledJanuary 30th, 2024 Company Industry JurisdictionIn view of the Borrower’s application for working capital loan line of credit from the Lender, and in order to clarify the rights and obligations of both parties, the Borrower and the Lender hereby conclude this contract through negotiation.
Corporate Loan ContractCorporate Loan Contract • January 30th, 2024 • Universe Pharmaceuticals INC • Pharmaceutical preparations
Contract Type FiledJanuary 30th, 2024 Company IndustryIn accordance with the provisions of relevant laws and regulations of China and on the basis of the principles of willingness, equality, mutual benefit and good faith, this Contract is hereby made by and between Party A and Party B with the consensus through negotiation.
Loan ContractLoan Contract • January 30th, 2024 • Universe Pharmaceuticals INC • Pharmaceutical preparations
Contract Type FiledJanuary 30th, 2024 Company IndustryThis Contract is a specific business contract under the Comprehensive Credit Contract (No. [A035808]) entered into by and between the creditor Nanchang Branch of Bank of Beijing Co., Ltd. and the debtor Jiangxi Universe Pharmaceuticals Co., Ltd.